NEW YORK, Oct. 19 - BSI Proteomics has been awarded three Small Business Innovation Research grants from the National Institutes for Health and NASA totaling $800,000, the company said on Friday.
BSI will use the money—$700,000 from the space agency and $100,000 from the NIH—to continue developing its Dynamically Controlled Crystallization System, or DCCS, platforms, according to the firm.
The awards bring to $4 million that BSI Proteomics has won in SBIR grants to date.
NIH approved its grant for BSI to develop its Automated Robotics Dynamically Controlled Crystallization System, also known as ARD, for high-throughput protein screening. Both the ARD and the DCCS platforms let the company “initiate, control, and monitor the entire protein crystallization process,” which BSI says can solve the “protein crystal bottleneck.”
NASA’s contribution, meanwhile, will be allocated to grow aboard the International Space Station Target Orphan Proteins that cannot be crystallized on Earth. A new BSI technology platform, the DCCS2, is currently under development and is earmarked for this project.